Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " August 07, 2013":" September 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" August 07, 2013":" September 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (37 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
2 Completed Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?
Condition: Tuberculosis
Intervention: Behavioral: TB reminders
3 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
4 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
5 Completed Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
Condition: HIV Disease
Intervention: Drug: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)
6 Unknown  IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
7 Recruiting Effect of Cenicriviroc on HIV Neurocognitive Impairment
Conditions: AIDS Dementia Complex;   HIV-1-Associated Cognitive Motor Complex;   Human Immunodeficiency Virus
Intervention: Drug: cenicriviroc
8 Active, not recruiting A Two Part, Open-label Study to Evaluate the Safety and Effectiveness of ABT-450/r/ABT-267 or ABT-450/r/ABT-267 and ABT-333 Given With or Without a Drug Called Ribavirin in People With Both Hepatitis C Virus Genotype 1 or 4 Infection and Human Immunodeficiency Virus, Type 1 Infection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
9 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
10 Active, not recruiting Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Interventions: Dietary Supplement: Zinc gluconate;   Dietary Supplement: Placebo
11 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
12 Unknown  Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV
Interventions: Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin;   Drug: Boceprevir
13 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
14 Recruiting Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Condition: HIV Infections
Interventions: Drug: Romidepsin;   Drug: Placebo for RMD: 0.9% sodium chloride for injection
15 Active, not recruiting Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
16 Withdrawn Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
17 Recruiting RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
Conditions: HIV/AIDS;   Stimulant Use Disorders
Interventions: Behavioral: Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS);   Behavioral: Contingency Management (CM)
18 Completed Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
Conditions: HIV;   Syphilis;   Anemia During Pregnancy
Interventions: Device: PIMA® for quantitative analysis of CD4-count;   Device: Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin;   Device: SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis
19 Unknown  The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
20 Completed Determining the Barriers and Motivations to Clinical Trial Participation
Condition: HIV

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years